|
A team of multidisciplinary scientists – including bioengineers, materials-scientists and immunologists – at the Wyss Institute has created a novel infection vaccine platform know as OmniVax. The unique biomaterial-based platform works by presenting antigens to the immune system in a controlled and sustained way, using a 3D scaffold containing the antigen that can be injected to mimic an infection under the skin.
|